The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of anlotinib plus penpulimab as first-line treatment for persistent, recurrent, or metastatic cervical cancer: Results from ALTER-GO-020 trial.
 
Dengfeng Wang
No Relationships to Disclose
 
Hong Liu
No Relationships to Disclose
 
Lihong Chen
No Relationships to Disclose
 
Mian He
No Relationships to Disclose
 
Weidong Zhao
No Relationships to Disclose
 
Yang Xiang
No Relationships to Disclose
 
Guoqinq Wang
No Relationships to Disclose
 
Guonan Zhang
No Relationships to Disclose